"Designing Growth Strategies is in our DNA"

Bleeding Disorders Therapeutics Market Size, Share and Global Trend By Product (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Anti-fibrinolytic, Fibrin Sealants), By Type (Hemophilia A, Hemophilia B, Von Willebrand Disease), By End Users (Hospitals, Ambulatory Surgical Centres, Specialty Clinics) and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI101169 | Status : Ongoing



A bleeding disorder is a term collectively used for medical conditions where the blood is unable to form clot properly. Frequent nose bleeding, heavy menstrual bleeding, excessive bruising, and extended bleeding after vaccination or surgery are some of the symptoms associated with bleeding disorders. They can be acquired or congenital. Hemophilia A & B and Von Willebrand's disease are the most common types of bleeding disorders among people. Others include vitamin K deficiency, factor II, V, VII, X, or XII deficiencies.

According to the World Federation of Hemophilia (WFH), it was estimated that the number of people with bleeding disorders increased by 6.8% from 2016 to 2017 which is likely to upsurge the demand for the effective therapies to treat the various bleeding disorders and additionally new product launches by many key players are likely to boost the growth of bleeding disorders therapeutics market during the forecast period.

To gain extensive insights into the market, Request for Customization

In March 2019, Biotest AG received the for usage of reduced Haemoctin SDH volume by half for the treatment of hemophilia A.This reduction in the solvent volume enhanced the quality life of the patient, especially in small children suffering with hemophilia A by minimizing the duration of injection and exposing less stress on the veins of small children.

Certain factors anticipated to accelerate the growth of the bleeding disorders therapeutics market during the forecast period are the presence of potential pipeline candidates in R&D, growing prevalence of Hemophilia, and an increase in the demand for cost-effective treatment options for the treatment of various bleeding disorders.

However, increasing cost of the treatment unaffordable by low-middle income countries is likely to hamper the growth of bleeding disorders therapeutics market during the forecast period.

Key Players Covered

Some of the major companies that are present in the global Bleeding Disorders Therapeutics market are Grifols, S.A., CSL, Octapharma, Shire, Kedrion S.p.A, China Biologic Products Holdings, Inc., Bayer AG, Pfizer Inc., Novo Nordisk A/S, others.




By Product

· Plasma-Derived Coagulation Factor Concentrates

· Recombinant Coagulation Factor Concentrates

· Desmopressin

· Anti-fibrinolytic

· Fibrin Sealants

· Others

By Type

· Hemophilia A

· Hemophilia B

· Von Willebrand Disease

· Others

By End Users

· Hospitals

· Ambulatory Surgical Centres

· Specialty Clinics

· Others

By Geography

· North America (U.S. and Canada)

· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

· Latin America (Brazil, Mexico, and Rest of Latin America)

· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)


Among product segmentation, the recombinant coagulation factor concentrates segment is anticipated to account for the largest share of global bleeding disorders therapeutics market during the forecast period owing to the growing usage of it as the most critical form of treatment for the Hemophilia A disease.

Key Insights

  • Reimbursement Scenario for Key Countries

  • Recent Industry Developments Such as Partnerships, Mergers, And Acquisitions

  • Pipeline Analysis

  • Advancements in Bleeding Disorder Therapeutics

  • Regulatory Scenario for Key Countries/Regions

Regional Analysis

Geographically, the global bleeding disorders therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are likely to dominate the bleeding disorders therapeutics the market during the forecast period owing to the increase in the prevalence bleeding disorders and growing investments in research activities by many key players in the development of novel products. In the Asia Pacific region, China and India are expected to be the fast emerging markets due to the rising awareness by government organizations about the various bleeding disorders & available treatment options and increase in the development of healthcare infrastructures.

Key Industry Developments

  • In March 2019, Biotest AG received the regulatory approval from 13 European countries for its product offering for the treatment of Hemophilia A, called Haematin SDH.

  • In February 2019, Novo Nordisk A/S received the U.S. FDA regulatory approval for its product offering of Esperoct (N8-GP) as a prophylactic treatment for Hemophilia A. It is an engineered formulation of factor VII developed by the company.

  • In November 2017, Grifols received the regulatory approval from the U.S. FDA for its product offering of fibrin sealant, which was composed of fibrinogen and human thrombin.

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.